9 results match your criteria: "4260University of Rhode Island[Affiliation]"
Int J Psychiatry Med
March 2023
PATHS Lab, Department of Psychology, 4260University of Rhode Island, Kingston, RI, USA.
Objective: The COVID-19 pandemic has led to substantial changes in college student alcohol use. Changes in drinking motives may explain some of these changes in drinking patterns. The purpose of the present study is to explore how drinking motives and alcohol use have changed amongst college students considering the timeframes before and after the onset of COVID-19 pandemic (i.
View Article and Find Full Text PDFAm J Alzheimers Dis Other Demen
March 2022
Cognitive Aging and Memory Program, McKnight Institute on Aging, 3463University of Florida, Gainesville, FL, USA.
Objectives: This study sought to explore feasibility, acceptability, and preliminary effects of aerobic training (AT), mindfulness training (MT), or both (MT + AT) on cognitive function in older individuals at risk of dementia.
Method: Participants were randomized to AT, MT, both, or usual care (UC). Z-scores of attention, verbal fluency, and episodic memory for non-demented adults (ZAVEN) were computed at baseline, end of treatment (EOT), and 6 months since baseline.
Psychol Rep
October 2022
Department of Psychology, The 4260University of Rhode Island, Kingston, RI, USA.
This study explored associations among test anxiety, GPA, sleep quality, and mood in college students. Data were collected from undergraduate students ( = 316). Results revealed that higher levels of test anxiety and sleep impairment predicted negative mood in undergraduates.
View Article and Find Full Text PDFJ Perioper Pract
October 2021
4260University of Rhode Island College of Pharmacy, Kingston, USA.
Background: Postoperative nausea and vomiting significantly increases recovery time, reduces patient satisfaction, and increases time to discharge. Consensus guidelines for the management of postoperative nausea and vomiting highlight effective methods for prophylaxis and treatment. Implications of adherence to these guidelines include both improved patient outcomes and reduced healthcare costs.
View Article and Find Full Text PDFAm J Health Promot
September 2021
Department of Political Science, 4260University of Rhode Island, Washburn Hall, Kingston, RI, USA.
Purpose: The relationship between civic engagement and mental health is generally positive, yet particularly complex among those from low socioeconomic backgrounds and women. The current study examined pathways between civic engagement and well-being to clarify its merit as a health promotional tool for young adults.
Design: Cross-sectional design using an online questionnaire.
Am J Hosp Palliat Care
July 2021
12262University of Massachusetts Medical School, Worcester, MA, USA.
Background: This study examined the feasibility, burden and acceptability of a legacy-making intervention in adults with cancer and preliminary effects on patient quality-of-life (QOL) measures.
Method: We conducted a Stage IB pilot, intervention study. The intervention was a digital video legacy-making interview of adults with advanced cancer to create a digital video of their memories and experiences.
Am J Hosp Palliat Care
July 2021
Department of Family Medicine and Community Health, Perelman School of Medicine, 6572University of Pennsylvania; Philadelphia, PA, USA.
Background: National oncology guidelines recommend early integration of palliative care for patients with cancer. However, drivers for this integration remain understudied. Understanding illness concerns at the time of cancer treatment may help facilitate integration earlier in the cancer illness trajectory.
View Article and Find Full Text PDFJ Pharm Pract
June 2021
College of Pharmacy, 4260University of Rhode Island, Kingston, RI, USA.
A rare disease, or orphan disease, in the United States is a condition with a national prevalence of fewer than 200,000 diagnoses. As therapies for rare diseases are developed and brought to market, pharmacists should understand the challenges of drug development for rare diseases and aid in educating patients about the approval process for rare disease therapies. Developing drugs for treating rare diseases presents unique challenges in proving the drug's safety and efficacy with adequate study design, power, and validity.
View Article and Find Full Text PDF